SBIO Short Volume
ALPS Medical Breakthroughs ETF (SBIO) operates in the Financial Services sector, specifically the Asset Management industry, with a market capitalization near $185.0M, listed on AMEX, carrying a beta of 0.99 to the broader market. The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. public since 2014-12-30.
Short volume measures the number of shares sold short on a given day as reported by FINRA. Tracking short volume relative to total volume helps identify unusual bearish sentiment or short-squeeze potential.
- Latest Date
- 2026-06-30
- Short Volume
- 28.0K
- Total Volume
- 34.0K
- Short %
- 82.29%
- 30-Day Avg Short %
- 38.49%
Showing 30 days of FINRA short volume data for ALPS Medical Breakthroughs ETF.
Learn how short volume is reported and how to read the data →
Frequently asked SBIO short volume questions
- What is the daily SBIO short volume?
- As of Jun 30, 2026, ALPS Medical Breakthroughs ETF (SBIO) short volume is 28.0K shares against 34.0K total reported volume, or 82.29% short-side. Short volume measures shares sold short during the day; it is flow, not inventory.
- How is SBIO short volume reported?
- FINRA publishes the Daily Short Sale Volume File for trades reported to FINRA TRFs and the FINRA/Nasdaq ADF on a T+1 basis. The headline figure is the count of shares that printed at the short-sale or short-exempt tick across all reporting venues for the symbol; each exchange separately publishes its own daily short-sale data file.
- What does SBIO short volume tell options traders?
- Daily short-sale flow is one input that helps disambiguate dealer-hedging activity from directional bear flow when the chain shows fresh customer call inventory. It is not a clean MM-only proxy: the headline number mixes directional shorting, options-MM delta-hedging, ETF-creation arbitrage, and convertible-arb hedging. Cross-check against gamma-exposure and OI changes for a cleaner read.